AzTrials
AzTrials

MothersNCT06958458

Empowering Mothers Whose Babies Are Hospitalized in the Neonatal Intensive Care Unit

A study testing Mother Integrated Care in people with Mothers and Premature, run by University of Yalova at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Family Integrated Care is designed to eliminate the barriers between parents and their infants in the NICU by involving parents of premature infants in their care. Parents are integrated into both the healthcare team and the care of their infant. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Mothers, Premature, Empowerment
What is being tested?
Mother Integrated Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
67 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Aug 2025to 1 Sep 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • The newborn must be premature (gestational age >28 and <34 weeks),
  • The infant must be admitted to the NICU and hospitalized for at least 3 days,
  • The mother must be open to communication and cooperation,
  • The mother must voluntarily agree to participate in the study,
  • The mother must be literate,
  • The mother must be able to speak and understand Turkish,
Show all 9Show fewer
  • The mother must be primiparous and experiencing motherhood for the first time,
  • The mother must be over 18 years of age,
  • Mothers in the intervention group must be present in the hospital for an average of 6-8 hours per day.

Who cannot join

  • The newborn has a congenital anomaly (e.g., craniofacial anomalies such as cleft palate, cleft lip, or facial muscle paralysis),
  • The newborn has a diagnosed gastrointestinal, neurological, or genetic disorder (e.g., necrotizing enterocolitis, hydrocephalus, Down syndrome, omphalocele, gastroschisis, short bowel syndrome, or other diseases),
  • The newborn has a congenital heart defect requiring surgical intervention,
  • The mother has a diagnosed psychiatric illness,
  • The mother and/or father do not wish to participate in the study.
  • Withdrawal Criteria:
Show all 11Show fewer
  • The mother does not attend the training sessions during the study period,
  • The mother fails to maintain cooperation throughout the study,
  • The newborn is transferred to another healthcare center for any reason,
  • The mother wishes to withdraw from the study,
  • The newborn is diagnosed with a chronic illness during the study process.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Yalova University

    Yalova, 77200

Other trials in Turkey (Türkiye)

About this study

Official title: Empowering Mothers Whose Babies Are Hospitalized in the Neonatal Intensive Care Unit and the Impact of Their Integration Into Their Babies' Care Process on Maternal and Infant Outcomes: A Randomized Controlled Trial

Family Integrated Care is designed to eliminate the barriers between parents and their infants in the NICU by involving parents of premature infants in their care. Parents are integrated into both the healthcare team and the care of their infant. Through this approach, parents are informed about how they can contribute to their infant's overall development, including neurological and sensory development, motor and behavioral progress, as well as practices such as touch, bonding, skin-to-skin contact, breastfeeding, and increasing breast milk production. They are also educated on general hygiene and care tasks such as diaper changing and body cleaning. This model places importance on the protection and enhancement of both the physical and psychological well-being of the parent and the infant. During this process, parents move beyond being mere "visitors" in the unit to becoming active "participants" and members of the care team. Family integrated care aims to support parents in becoming the primary caregivers for their infants, both during hospitalization and after discharge. This model not only provides education and counseling but also supports the family's comprehensive involvement in the infant's care.

Being tested
Mother Integrated Care
Keywords
Empowerment, Neonatal, Premature, Mothers, Nursing
Medical subject headings
Premature Birth, Empowerment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mother Integrated CareBehavioural

    In order to empower mothers whose premature infants have been hospitalized in the neonatal intensive care unit (NICU) for at least three days, a four-step neonatal care training program will be provided. Through the empowerment of the mother, the empowerment of the motherwill also be supported. The family will no longer be considered as visitors but will be involved in the infant's care in the NICU as parents. Data collection forms will be completed before the training begins, one day prior to discharge, and one week after discharge.

Study groups in NCT06958458
Study groupRoleWhat they receive
Mother Integrated Care GroupExperimentalMothers whose babies are admitted to YYÜ will be contacted within the first 72 hours. Pre-test data (Information Form, Maternal Self-Efficacy, Attachment, Breastfeeding Self-Efficacy, Parental Stress, and Newborn Comfort Scales) will be collected, and the training schedule will be determined through face-to-face interviews. After the interview with the mother and the pre-test are completed, the training date will be determined in consultation with the researchers. The training, consisting of four stages, is planned to be conducted at a rate of one session per day. Procedures will be demonstrated using mannequins and supported by a PowerPoint presentation and visual materials. A prepared booklet will also be distributed to the mothers. After the training phases are completed, mothers will be encouraged to participate in care as part of a team effort. One day before discharge and one and three months after discharge, survey forms will be completed via WhatsApp.
Receives: Behavioral: Mother Integrated Care
Control groupNo interventionMothers in this group will receive standard unit care and education. Data collection procedures will be the same as those used in the intervention group. The mother will be contacted within the first 72 hours after admission to the unit, and baseline data will be collected. One day before discharge, and one and three months after discharge, questionnaire forms will be completed via WhatsApp.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Parental Stress in the Neonatal Intensive Care Unit

    The Parental Stressor Scale: Neonatal Intensive Care Unit (PSS:NICU) will be used to assess the level of parental perception of stressors arising from the physical and psychosocial environment of the intensive care unit. The scale consists of 34 items across three dimensions: Sights and Sounds, Infant Appearance and Behavior, and Parental Role Alteration. Higher scores on the scale indicate higher levels of parental stress (minimum: 0, maximum: 170).

    Measured: Within the first 72 hours of hospitalization, prior to discharge

  2. Maternal Attachment

    The Maternal Attachment Scale consists of 26 items. The total score can range from 26 to 104. A higher score indicates a higher level of maternal attachment.

    Measured: Within the first 72 hours of hospitalization, prior to discharge, 1 month after discharge, and months after discharge

  3. The Mother's Perceived Parenting Self-Efficacy

    The scale was developed to assess the perceived self-efficacy of mothers of premature infants in caring for their babies and understanding their needs. The scale consists of a total of 20 items, and scores range from 20 to 80. A higher score indicates an increase in the mother's perceived parenting self-efficacy.

    Measured: Within the first 72 hours of hospitalization, prior to discharge, 1 month after discharge, and months after discharge

  4. Breastfeeding Self-Efficacy Scale for Mothers of Preterm Infants

    The scale consists of 18 positive items that assess mothers of preterm infants' perceptions of self-efficacy regarding breastfeeding and milk expression. The total score ranges from 18 to 90, with a high score indicating high breastfeeding self-efficacy.

    Measured: Within the first 72 hours of hospitalization, prior to discharge, 1 month after discharge, and months after discharge

  5. Newborn Comfort Behavior

    The scale consists of six behavioral parameters that assess alertness, calmness/agitation, respiratory response or crying, body movements, facial tension, and muscle tone. Each parameter is scored on a scale of 1 to 5, and the total score ranges from 6 to 30. A high score indicates a decreased level of comfort in the newborn.

    Measured: Within the first 72 hours of hospitalization, prior to discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2025
  2. Study start30 Aug 2025
  3. Primary completion30 Aug 2026
  4. Study completion1 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a randomized controlled trial (RCT) designed to evaluate the effectiveness of an intervention.
Masking
None (open label)
Enrolment
67 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06958458
Sponsor's protocol ID
Emel A. Family Integrated Care
Status last verified
Sep 2026
First submitted
18 Apr 2025
Last updated
21 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Mother Integrated Care in people with Mothers and Premature, run by University of Yalova at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Parental Stress in the Neonatal Intensive Care Unit (time frame: Within the first 72 hours of hospitalization, prior to discharge). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in